Kangmei Pharma | 600518 - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Genomma Lab Internacional MXN 2.81B 264.13M 2026-03
Hypermarcas BRL 2.31B 665.36M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Jiangsu Hengrui CNY 40.96B 591.41M 2025-12
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Moderna USD 1.91B 687M 2026-03
Organon & Co USD 1.12B 542M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Sh Fosun Pharma CNY 13.1B 1.63B 2025-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Viatris USD 1.8B 481.8M 2026-03
Wuxi Apptec CNY 35.91B 773.93M 2026-03
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03